Robert Balk to Interleukin 1 Receptor Antagonist Protein
This is a "connection" page, showing publications Robert Balk has written about Interleukin 1 Receptor Antagonist Protein.
Connection Strength
0.017
-
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med. 1997 Jul; 25(7):1115-24.
Score: 0.010
-
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA. 1994 Jun 15; 271(23):1836-43.
Score: 0.008